Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective multicenter study of precise diagnosis and intervention strategies for elderly sleep-related movement disorders
ChiCTR2000035733Phase 4Not yet recruiting
- Sponsor
- Fudan University
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pramipexole and gabapentin in restless legs syndrome (RLS), sleep-related movement disorders (SRMD), Insomnia and 1 more (4 arms), sponsored by Fudan University. Primary endpoint: score of IRLSSG rating scale. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
pramipexolegabapentin
03
Conditions
restless legs syndrome (RLS)sleep-related movement disorders (SRMD)Insomniacircadian rhythm sleep disorder (CRSD)
Beyond the preview
Go deeper on ChiCTR2000035733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035733.